We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App





AACC Debuts Refreshed Brand Identity

By LabMedica International staff writers
Posted on 29 Jul 2014
Print article
The American Association for Clinical Chemistry (AACC; Washington DC, USA), the global scientific and medical professional organization dedicated to better health through laboratory medicine, unveiled an updated brand identity today, which reflects the organization’s commitment to help laboratory professionals adapt to the changing healthcare environment and continue to do what they do best: provide vital insight to physicians, so patients get the care they need. AACC's updated look reflects the organization’s focus on better health through laboratory medicine.

The official launch of AACC's updated identity with the opening of the 2014 AACC Annual Meeting & Clinical Lab Expo, and the redesign and update of AACC’s magazine, Clinical Laboratory News will continue to be rolled out throughout the year.

Janet B. Kreizman, AACC CEO said, “The laboratory professionals that make up AACC’s membership play an essential role in saving lives and making people healthier. With this updated brand identity, we created a visual shorthand to show that AACC promotes new thinking and new skills to help laboratory professionals address the complexity of an evolving healthcare landscape while working to advance patient health.”

Steven H. Wong, PhD, DABCC, FACB added, “AACC works to inspire scientific breakthroughs and provide essential, clinically-relevant content, so laboratory professionals can discover new adaptive solutions that advance patient care and bring better health to all people. We have a new look, but our vision remains the same: better health through laboratory medicine.”

To view AACC’s updated brand identity, please visit the organization’s website (please see Related LInks below).

Related Links:

AACC 


Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Chlamydia Trachomatis Assay
Chlamydia Trachomatis IgG
New
Nutating Mixer
Enduro MiniMix

Print article

Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.